Abbott Laboratories ROA 2006-2018 | ABT

Current and historical return on assets (ROA) values for Abbott Laboratories (ABT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Abbott Laboratories ROA for the three months ending December 31, 2018 was 7.30%.
Abbott Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $2.37B $0.00B 4.49%
2018-09-30 $0.89B $71.64B 1.23%
2018-06-30 $0.93B $68.42B 1.29%
2018-03-31 $0.48B $70.91B 0.66%
2017-12-31 $0.48B $76.25B 0.66%
2017-09-30 $2.10B $72.25B 3.15%
2017-06-30 $1.17B $71.15B 2.00%
2017-03-31 $1.50B $70.89B 2.96%
2016-12-31 $1.40B $52.67B 3.26%
2016-09-30 $1.37B $39.50B 3.42%
2016-06-30 $2.28B $39.83B 5.61%
2016-03-31 $2.45B $39.64B 5.87%
2015-12-31 $4.42B $41.25B 10.40%
2015-09-30 $4.56B $41.73B 10.72%
2015-06-30 $4.52B $44.13B 10.57%
2015-03-31 $4.20B $43.10B 9.99%
2014-12-31 $2.28B $41.21B 5.48%
2014-09-30 $1.97B $42.51B 4.67%
2014-06-30 $2.40B $41.48B 5.63%
2014-03-31 $2.41B $41.66B 5.61%
2013-12-31 $2.58B $42.95B 5.97%
2013-09-30 $3.04B $44.13B 6.17%
2013-06-30 $4.02B $42.90B 7.43%
2013-03-31 $5.27B $42.69B 8.96%
2012-12-31 $5.96B $67.24B 9.36%
2012-09-30 $6.53B $63.26B 10.54%
2012-06-30 $4.89B $61.86B 8.01%
2012-03-31 $5.11B $62.42B 8.36%
2011-12-31 $4.73B $60.28B 7.77%
2011-09-30 $4.55B $59.63B 7.47%
2011-06-30 $5.14B $62.00B 8.51%
2011-03-31 $4.49B $61.65B 7.71%
2010-12-31 $4.63B $60.57B 8.24%
2010-09-30 $4.73B $57.37B 8.72%
2010-06-30 $5.31B $53.38B 10.16%
2010-03-31 $5.31B $53.36B 10.44%
2009-12-31 $5.75B $52.58B 11.76%
2009-09-30 $5.74B $49.85B 12.39%
2009-06-30 $5.35B $47.63B 12.07%
2009-03-31 $5.38B $45.44B 12.39%
2008-12-31 $4.88B $42.42B 11.52%
2008-09-30 $4.55B $41.75B 10.91%
2008-06-30 $4.18B $44.07B 10.28%
2008-03-31 $3.85B $41.18B 9.89%
2007-12-31 $3.61B $39.71B 9.57%
2007-09-30 $1.93B $37.62B 5.24%
2007-06-30 $1.93B $37.15B 5.39%
2007-03-31 $1.55B $36.29B 4.43%
2006-12-31 $1.72B $36.18B 5.20%
2006-09-30 $3.17B $33.30B 10.14%
2006-06-30 $3.13B $34.06B 10.40%
2006-03-31 $3.40B $28.53B 11.89%
2005-12-31 $3.37B $29.14B 11.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $132.673B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14